Leonteq Securities AG’s Integra LifeSciences IART Stock Holding History

Leonteq Securities AG’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$826	Hold	46	–	–	﹤0.01%	1186
2026 Q1	$433	Hold	46	–	–	﹤0.01%	1227
2025 Q4	$571	Hold	46	–	–	﹤0.01%	1363
2025 Q3	$659	Hold	46	–	–	﹤0.01%	1263
2025 Q2	$564	Hold	46	–	–	﹤0.01%	1217
2025 Q1	$1.01K	Hold	46	–	–	﹤0.01%	1166
2024 Q4	$1.04K	Hold	46	–	–	﹤0.01%	1187
2024 Q3	$836	Hold	46	–	–	﹤0.01%	1130
2024 Q2	$1.34K	Hold	46	–	–	﹤0.01%	1124
2024 Q1	$1.63K	Hold	46	–	–	﹤0.01%	1142
2023 Q4	$2K	Sell	46 -7	-13%	-$275	﹤0.01%	1120
2023 Q3	$2.02K	Hold	53	–	–	﹤0.01%	1130
2023 Q2	$2.18K	Hold	53	–	–	﹤0.01%	1155
2023 Q1	$3.04K	Hold	53	–	–	﹤0.01%	1135
2022 Q4	$2.97K	Hold	53	–	–	﹤0.01%	1177
2022 Q3	$2.25K	Sell	53 -375	-88%	-$19.2K	﹤0.01%	1182
2022 Q2	$23.1K	Buy	428 +65	+18%	+$3.9K	﹤0.01%	958
2022 Q1	$23.3K	Sell	363 -29	-7%	-$1.91K	﹤0.01%	987
2021 Q4	$26.3K	Hold	392	–	–	﹤0.01%	1001
2021 Q3	$26.8K	Buy	+392	New	+$27.7K	﹤0.01%	930

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Leonteq Securities AG's IART Position: Q2 2026 in Review

Leonteq Securities AG held its Integra LifeSciences (IART) position steady in Q2 2026 at 46 shares worth $826. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Leonteq Securities AG first reported a position in IART in Q3 2021 and has held it in 20 quarters since. The position peaked at $26.8K in Q3 2021. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Leonteq Securities AG held 46 shares of Integra LifeSciences worth $826 as of Q2 2026.
Leonteq Securities AG left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1186 holding.
Leonteq Securities AG first reported a position in Integra LifeSciences in Q3 2021 and has held it in 20 quarters since.
Leonteq Securities AG's Integra LifeSciences position peaked at $26.8K in Q3 2021.
211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.